These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

641 related articles for article (PubMed ID: 8048682)

  • 21. Performances of copper T 380A and multiload copper 375/250 intrauterine contraceptive devices in a comparative clinical trial.
    Arowojolu AO; Otolorin EO; Ladipo OA
    Afr J Med Med Sci; 1995 Mar; 24(1):59-65. PubMed ID: 7495202
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Duration of lactation and return of menstruation in lactating women using hormonal contraception and IUDs.
    Prema K
    Contracept Deliv Syst; 1982 Jan; 3(1):39-46. PubMed ID: 12264126
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The end of IUD marketing in the United States: what does it mean for American women?].
    Forrest JD
    Contracept Fertil Sex (Paris); 1987 Mar; 15(3):291-300. PubMed ID: 12341479
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The relationship between vascular headaches and low-dose oral contraceptives.
    Karsay K
    Ther Hung; 1990; 38(4):181-5. PubMed ID: 2094059
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Current status of contraceptive steroids and the intrauterine device.
    Mishell DR
    Clin Obstet Gynecol; 1974 Mar; 17(1):35-51. PubMed ID: 4596680
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Women's satisfaction with birth control: a population survey of physical and psychological effects of oral contraceptives, intrauterine devices, condoms, natural family planning, and sterilization among 1466 women.
    Oddens BJ
    Contraception; 1999 May; 59(5):277-86. PubMed ID: 10494480
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A randomized clinical trial of the effect of intensive versus non-intensive counselling on discontinuation rates due to bleeding disturbances of three long-acting reversible contraceptives.
    Modesto W; Bahamondes MV; Bahamondes L
    Hum Reprod; 2014 Jul; 29(7):1393-9. PubMed ID: 24812309
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pregnancy-specific beta 1-glycoprotein and chorionic gonadotropin-like immunoreactivity during the latter half of the cycle in women using intrauterine contraception.
    Seppälä M; Rutanen EM; Jalanko H; Lehtovirta P; Stenman UH; Engvall E
    J Clin Endocrinol Metab; 1978 Dec; 47(6):1216-9. PubMed ID: 318094
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Comparative study of the acceptability of inert and copper-containing intrauterine contraceptive devices].
    Manuilova IA; Dubnitskaia LV
    Akush Ginekol (Mosk); 1988 Nov; (11):47-50. PubMed ID: 3239684
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Contraceptives for lactating women: a comparative trial of a progesterone-releasing vaginal ring and the copper T 380A IUD.
    Sivin I; Díaz S; Croxatto HB; Miranda P; Shaaban M; Sayed EH; Xiao B; Wu SC; Du M; Alvarez F; Brache V; Basnayake S; McCarthy T; Lacarra M; Mishell DR; Koetsawang S; Stern J; Jackanicz T
    Contraception; 1997 Apr; 55(4):225-32. PubMed ID: 9179454
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Use of IUDs in developing countries: a comparative study.
    Farr G; Burdan A
    Netw Res Triangle Park N C; 1991 Sep; 12(2):6-8, 12. PubMed ID: 12284280
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Menstrual impact of contraception.
    Stubblefield PG
    Am J Obstet Gynecol; 1994 May; 170(5 Pt 2):1513-22. PubMed ID: 8178900
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Experience with the copper 7 intrauterine device in an adolescent population.
    Kulig JW; Rauh JL; Burket RL; Cabot HM; Brookman RR
    J Pediatr; 1980 Apr; 96(4):746-50. PubMed ID: 7359288
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Preliminary report on a postpartum CuT 200 study, Santiago, Chile.
    Lavin P; Waszak C; Bravo C
    Int J Gynaecol Obstet; 1983 Feb; 21(1):71-5. PubMed ID: 6133798
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Different contraceptive practices: use of contraceptives in Finland and other Nordic countries in the 1970s and 1980s.
    Makkonen K; Hemminki E
    Scand J Soc Med; 1991 Mar; 19(1):32-8. PubMed ID: 1925424
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A two-year clinical study of the effects of two triphasic oral contraceptives on plasma lipids.
    Kakis G; Powell M; Marshall A; Woutersz TB; Steiner G
    Int J Fertil Menopausal Stud; 1994; 39(5):283-91. PubMed ID: 7820162
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Acceptability of IUDs is increasing.
    Finger WR; Barr D
    Netw Res Triangle Park N C; 1992 Oct; 13(2):27-30. PubMed ID: 12286082
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Post coital contraception.
    Haspels AA; Van Santen MR
    J Gynaecol Endocrinol; 1986; 2(1-2):17-24. PubMed ID: 12269214
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Canadian Contraception Consensus (Part 3 of 4): Chapter 7--Intrauterine Contraception.
    Black A; Guilbert E; Costescu D; Dunn S; Fisher W; Kives S; Mirosh M; Norman W; Pymar H; Reid R; Roy G; Varto H; Waddington A; Wagner MS; Whelan AM; Mansouri S
    J Obstet Gynaecol Can; 2016 Feb; 38(2):182-222. PubMed ID: 27032746
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Use-effectiveness of oral and intrauterine contraception.
    Tietze C; Lewitt S
    Fertil Steril; 1971 Aug; 22(8):508-13. PubMed ID: 5110233
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 33.